Lexpert Special Editions

Lexpert Special Edition on Health Sciences

The Lexpert Special Editions profiles selected Lexpert-ranked lawyers whose focus is in Corporate, Infrastructure, Energy and Litigation law and relevant practices. It also includes feature articles on legal aspects of Canadian business issues.

Issue link: https://digital.carswellmedia.com/i/1379015

Contents of this Issue

Navigation

Page 9 of 43

8 www.lexpert.ca Feature patients for whom a specific treatment will work. "e more we're using AI now and soware and genetic testing to get that infor- mation, [the more we will] have more targeted therapeutic regimes to the individual." Psychedelics and cannabis e psychedelics market is very active now, Reicin adds, and some players have shied to it from the cannabis sector. "Canada was a leader in the cannabis market and continues to be a leader in psychedelics, too." In early May, Tilray Inc. and Aphria Inc. announced their merger's closing, which created the world's largest cannabis company by revenue. But the merger continues consol- idation in the sector rather than representing a shi. ere has been "a bit of a consolidation play" in the cannabis sector for a while, says Clemens Mayr, a partner in McCarthy Tétrault LLP's Montreal office. Despite the "big hype" in the cannabis space a few years ago, many smaller players were and are struggling, he says. Now that the sector is maturing, "some of the larger players are completing this consolidation trend." at consolidation will be similar to that in the tobacco and liquor industries as the cannabis industry matures, says Reicin. Proprietary or unique medical cannabis products may form part of niche businesses, but one or two handfuls of companies will control recreational cannabis, she predicts. Products made from cannabidiol — the second most prevalent active ingredient in cannabis known as "CBD" — are being increasingly investigated and tried as ther- apeutic alternatives to chemical medicines, says Mayr, who expects global growth in the medicinal cannabis sector. "I don't think recreational cannabis, which was at the origin of the hype, is really the long-term value creator in this space," Mayr says. However, he says, much will depend on what the United States does; 36 states, the District of Columbia and most U.S. terri- tories had legalized the use of cannabis for medicinal purposes by late 2020, but at the federal level, it remains a prohibited substance. A SAMPLING OF TOP TELEHEALTH APPS • Maple telehealth app: Connects patients to doctors via phone, tablet or computer, 24/7 • Babylon by TELUS Health: Allows patients to see a doctor on their phone, check symptoms, and get prescriptions or referrals • Akira Healthcare On-Demand: Offers on-demand access to health-care providers via text and video • Ask a Doctor: Allows users to write a health query, attach a picture or lab report and post to doctors around the world • Dialogue: Allows patients to consult with health-care professionals by chat, audio or video • Livecare ConnectM: Connects patients to doctors, allows patients to store their medical files on Livecare's server

Articles in this issue

Links on this page

Archives of this issue

view archives of Lexpert Special Editions - Lexpert Special Edition on Health Sciences